vision sciences inc. ( nasdaq : vsci ) is an international endoscopy product manufacturer and supplier .

it was founded in 1987 by lewis c. pell and katsumi oneda and is based in orangeburg , new york .

in december 2013 , the company has been selected by 21st century oncology inc. as 21st century ’s preferred vendor of choice and its products will be applied in medical treatment in a variety of therapeutic areas including cancer care .

vision sciences inc .

vision - sciences inc . ; vision - sciences , inc . announces new executive vice - president and chief financial officer
vision - sciences , inc . tne system offers solution for sedation concerns | biospace
vision - sciences , inc . ron hadani , ceo 845 - 365 - 0600
vision - sciences inc . ; vision - sciences , inc . announces new executive vice - president and chief financial officer - abn newswire ( @ abn _ newswire )
vision - sciences , inc . announces new executive vice - president and chief financial officer
. . . - for - stock merger of pell’s vision - sciences inc . and rob kill’s uroplasty inc . after the merger . . .
contact : vision - sciences , inc . christian escobar , marketing manager 845 - 365 - 0600
vision - sciences owns the registered trademarks vision sciences® , endosheath® , endowipe® , slide - on® , and the vision system® .
vision - sciences , inc . announces new executive vice - president and chief financial officer nasdaq : vsci
vision - sciences , inc . announces election of new director - business - press releases | nbc news
. . . inc . and vision - sciences inc . as a result of which the former uroplasty stockholders held 62 . 5 percent of . . .
vision‑sciences owns the registered trademarks vision sciences ® , slide - on ® , endosheath ® and the vision system ® . information about vision - sciences ' products is available at urltoken .
contact : vision - sciences , inc . ron hadani , ceo + 1 - 845 - 365 - 0600
vision - sciences , inc . receives ce clearance and health canada approval to market its video - based advanced endoscopy lines
contact : vision - sciences , inc . katherine wolf , cfo & evp , corporate development ( 845 ) 365 - 0600
. . . achieve those goals . the drama stems from the march 2015 merger of pell’s vision - sciences inc . . .
, vision - sciences , inc . designs , develops , manufactures and markets products for flexible endoscopy . the company ' s unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier , known as endosheath technology , providing users with efficient and cost effective endoscope turnover while enhancing patient safety . for more information on vision - sciences and its products , please visit vision - sciences , inc . at
terms of service | privacy policy | © 2018 crunchbase inc . all rights reserved .
signature mapping medical sciences , inc . ( smms ) is a wholly - owned subsidiary focused on the development of computer vision automated medical diagnostic and decision support software solutions .
in connection with the proposed merger , vision - sciences plans to file with the sec a registration statement on form s - 4 that will include a joint proxy statement of uroplasty and vision - sciences that also constitutes a prospectus of vision - sciences . uroplasty and vision - sciences will make the joint proxy statement / prospectus available to their respective shareholders .
vision - sciences , inc . ( nasdaq : vsci ) develops , manufactures and markets unique flexible endoscopic products for a variety of markets . for more information , please visit us at urltoken
vision - sciences , inc . ( nasdaq : vsci ) develops , manufactures and markets unique flexible endoscopic products for a variety of markets . for more information , please visit us at urltoken
vision - sciences , inc . designs , develops , manufactures and markets products for flexible endoscopy . the company ' s unique product lines feature a streamlined visualization system and proprietary sterile , disposable microbial barrier , known as endosheath® technology , providing users with efficient and cost effective endoscope turnover while enhancing patient safety . information about vision - sciences ' products is available at urltoken .
by internet : under the
investors
tabs at the uroplasty website at urltoken and vision - sciences website at urltoken .
orangeburg , n . y . , dec . 15 , 2010 ( globe newswire ) - - vision - sciences , inc . , ( nasdaq : vsci ) ( vision - sciences ) , announced today that its board of directors elected dr . bruce polsky to serve as a member of its board , effective immediately . dr . polsky will be an independent member of the board .
orangeburg , n . y . , june 3 , 2008 ( prime newswire ) - - vision - sciences , inc . , ( nasdaq : vsci ) (
vision - sciences
) , announced today that it received approval from underwriters laboratories inc . to affix the ce mark to its new line of advanced digital , video - based flexible endoscopes , which come with an integrated
built - in
light source , eliminating the need for a separate camera head , light cable and optical coupler . vision - sciences also announced health canada approval for these scopes . with health canada ' s approval , and the approval of applicable technical files and updated ec certificates , vision - sciences is now permitted to distribute and sell its scopes throughout all eu countries and canada .
, vision - sciences ' chairman . these notes and warrants have been amended in connection with the merger , as described below .
vision sciences , a medical device company , develops flexible endoscopes as a control solution to decrease the risk of cross - contamination .
vision - sciences , inc . designs , develops , manufactures and markets unique flexible endoscopic products utilizing sterile disposable sheaths , the slide - on ® endosheath ® technology , which provide the users quick , efficient product turnover while ensuring the patient a contaminant - free product .
is acting as exclusive financial advisor to uroplasty . leerink partners is acting as exclusive financial advisor to vision - sciences . oppenheimer wolff & donnelly llp is acting as counsel for uroplasty , and royer cooper cohen braunfeld llc is acting as counsel for vision - sciences .
orangeburg , n . y . , sept . 16 , 2008 ( globe newswire ) - - vision - sciences , inc . ( nasdaq : vsci ) today announced that katherine wolf has been named as the company ' s executive vice - president , corporate development and chief financial officer , effective today . in this role she will be responsible for all of vision - sciences ' financial operations and business development activities .
orangeburg , n . y . , sept . 16 , 2008 ( globe newswire ) - - vision - sciences , inc . ( nasdaq : vsci ) today announced that katherine wolf has been named as the company ' s executive vice - president , corporate development and chief financial officer , effective today . in this role she will be responsible for all of vision - sciences ' financial operations and business development activities .
vision - sciences , inc . and its subsidiaries designs , develops , manufactures , and markets products for endoscopy - the science of using an instrument , known as an endoscope , to provide minimally invasive access to areas not readily visible to the human eye . our products are sold throughout the world
gilead sciences , inc . is a research - based biopharmaceutical company that discovers , develops and commercializes innovative medicines in areas of unmet medical need . we strive to transform and simplify care for people with life - threatening illnesses around the world .
vision - sciences , inc . ( nasdaq : vsci ) develops , manufactures and markets unique flexible endoscopic products for the urology , gastroenterology and the ent markets , utilizing the proprietary sterile disposable endosheath ( r ) technology . this technology provides quick and efficient equipment turnover , and ensures the patient a contaminant - free endoscope insertion .
i am excited to join a company with such great potential ,
said ms . wolf .
i think vision - sciences ' technology and management creates a tremendous opportunity . i look forward to joining the rest of the team as we implement vision - sciences ' financial , business development and operational strategies .
i am extremely pleased to welcome bruce to the board . his extensive medical background and knowledge of infectious diseases add significantly to our organization ,
said lewis pell , chairman of vision - sciences . dr . polsky was elected as a class ii director , to serve until vision - sciences ' 2011 annual shareholders ' meeting . dr . polsky was nominated to be reelected to the board at vision - sciences ' annual shareholders ' meeting , expected to be held in september 2011 .
copyright © 2014 applied visual sciences , all rights reserved . terms of use |
guardian technologies international , inc . ( gdti ) is a wholly - owned subsidiary focused on the development of automated target recognition software solutions for the homeland security and military marketplaces .
following the closing of the transaction , which is expected to occur during the first half of 2015 , the combined company will conduct business as cogentix medical , inc . ( nasdaq :
) and from uroplasty and vision - sciences . requests for copies of the joint proxy statement / prospectus and other documents filed by uroplasty with the sec may be made by contacting
, as well as both companies ' subsequent quarterly reports on form 10 - q and other information filed by each company with the sec . uroplasty and vision - sciences caution investors not to place considerable reliance on the forward - looking statements contained in this press release . you are encouraged to read uroplasty ' s and vision - sciences ' filings with the sec , available at
the merger of uroplasty and vision - sciences will create a medical device company positioned for growth with proprietary , innovative technologies serving the urology market . in addition to the minimally - invasive urgent pc and macroplastique product lines , uroplasty ' s 44 person u . s . sales organization , along with vision - sciences ' 12 person u . s . sales organization , will aggressively market vision - sciences ' proprietary endosheath technology platform . internationally , the combined company ' s products will be sold through uroplasty ' s eight direct sales representatives as well as the current distributors of both companies .
uroplasty , vision - sciences , their respective directors , executive officers and employees may be deemed to be participants in the solicitation of proxies from uroplasty ' s and vision - sciences ' respective shareholders in connection with the proposed transaction . information about the directors and executive officers of uroplasty and their ownership of uroplasty stock is set forth in uroplasty ' s annual report on form 10 - k for the fiscal year ended
. these documents can be obtained free of charge from the sources indicated above . certain directors , executive officers and employees of uroplasty and vision - sciences may have direct or indirect interest in the transaction due to securities holdings , vesting of equity awards and rights to severance payments . additional information regarding the participants in the solicitation of uroplasty and vision - sciences shareholders will be included in the joint proxy statement / prospectus filed with the sec .
, 2015 . once the existing uroplasty sales team is fully trained on the vision - sciences ' product line , the new company is expected to achieve sustainable annual revenue growth of 15 % beginning with its second fiscal year .
katherine has tremendous experience in healthcare investment banking and finance , which will be invaluable to vision - sciences as we continue to expand the applications for our technologies ,
said ron hadani , president and ceo of vision - sciences .
her background in capital markets , her reputation among the financial community and a deep understanding of our business make her uniquely qualified to help us expand on opportunities to capitalize on our revolutionary videoscope and other new technologies .
under the terms of the agreement , which was unanimously approved by the boards of directors of both companies , each outstanding share of uroplasty ' s common stock will be exchanged for 3 . 6331 shares of vision - sciences ' common stock . upon completion of the merger , uroplasty shareholders will own 62 . 5 % of the shares of the combined company on a fully - diluted basis , and vision - sciences shareholders will own 37 . 5 % . [ 1 ]
, who will become senior vice president of global sales and marketing . cogentix medical ' s board of directors will be comprised of the five representatives from uroplasty ' s existing board and three representatives from vision - sciences ' existing board .
, for a discussion of these and other risks and uncertainties . the forward - looking statements in this press release speak only as of the date of this release , and uroplasty and vision - sciences undertake no obligation to update or revise any of these statements . uroplasty ' s and vision - sciences ' businesses are subject to substantial risks and uncertainties , including those referenced above . investors , potential investors , and others should give careful consideration to these risks and uncertainties .
, president and ceo of uroplasty .
we are confident that offering vision - sciences ' urology product lines to our core urology customer base will also make us more meaningful and valuable to those customers . at the same time , we expect that the increased focus by care providers on endoscopic efficiency and prevention of cross - contamination creates significant growth opportunity for vision - sciences ' endosheath technology in adjacent markets such as ent and pulmonology . with more than five million units sold and zero reported cases of cross contamination , we believe that endosheath products will be the standard of care for endoscopic applications , and our team fully intends to turn this efficacy leadership into market leadership . we look forward to working with the vision - sciences ' team to enhance shareholder value through this combination .
vision - sciences ' new digital scopes employ our proprietary endosheath ( r ) technology . unlike endoscopes from other manufacturers , vision - sciences ' new advanced video scopes do not contain difficult - to - clean operating channels . instead , our video scopes utilize our patented , disposable , sterile slide - on ( r ) endosheath ( r ) technology which covers the entire endoscope . each disposable sheath contains a sterile operative channel , which eliminates patient tissue or organic matter from coming into contact with the reusable endoscope or the next patient .
dr . polsky commented ,
i am delighted to join the board of vision - sciences . i believe the company ' s endosheath technology for flexible endoscopy is unique , providing sterile , efficient endoscopic procedures without the traditional complexities and difficulties associated with conventional endoscopy .
the named executive officers and directors of each company , representing approximately 4 . 2 % and 39 . 1 % of uroplasty ' s and vision - sciences ' outstanding common stock respectively , evidenced their support by entering into voting agreements to vote in favor of the transaction .
cogentix medical , inc . , formerly vision - sciences , inc . , is a medical device company . the company designs , develops , manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier , endosheath technology . the company produces and markets endoscopes , such as cystoscopes , ureteroscopes , laryngoscopes , otoscopes , sinuscopes , trans - nasal esophagoscopy ( tne ) and bronchoscopes for medical use and borescopes for industrial use , and digital processing units ( dpu ) . the company offers urgent pc neuromodulation system , a nerve stimulation device that delivers percutaneous tibial nerve stimulation ( ptns ) for the office - based treatment of overactive bladder ( oab ) . it also offers macroplastique , an injectable , urethral bulking agent for the treatment of adult female stress urinary incontinence . it markets additional bulking agents : ptq for the treatment of fecal incontinence and the vox for vocal cord augmentation .
orangeburg , n . y . , oct . 27 , 2014 ( globe newswire ) - - the report by the new york city office of the chief medical examiner on the death of joan rivers points to a
predictable complication of medical therapy .
vision - sciences ( nasdaq : vsci ) believes one solution to these complications is a sedation - free exam for the patient . the vision sciences® tne endoscopy system with patented endosheath® technology offers physicians the ability to visualize , diagnose , and treat a patient ' s upper airway , throat , esophagus , and stomach without the need for the complications of sedation .
we are very excited to be able to begin shipping orders to our european and canadian customers ,
stated ron hadani , president and chief executive officer vision - sciences .
we will now be able to meet the medical community ' s overwhelming interest in our products , and expand our opportunities in the european and canadian markets .
a key necessity in stopping the growth of esophageal cancer is a safe , cost - effective , efficient diagnostic option for physicians ,
stated howard zauberman , president and chief executive officer of vision - sciences .
we believe our tne system combined with our endosheath technology provides the ideal instrument for the mounting need in diagnosing and managing esophageal disorders .
since joining vision - sciences in 2006 , mr . yoav m . cohen has served as our chief financial officer and until april 2008 , as our acting chief operating officer . mr . cohen is returning to nyc advisors , llc , a financial advisory firm located in white plains , new york , as its managing partner , and will continue to devote his time and substantial efforts working closely with us on accounting and financial projects .
yoav has provided outstanding support to vision - sciences , as we continue to grow ,
said mr . hadani .
under yoav ' s leadership and guidance , we have updated and modernized our accounting , financial and operational systems , and we look forward to his continued contribution .
the vision - sciences innovative endoscopy technology and the transnasal approach avoid the use of propofol sedation , allowing patients to undergo the diagnostic exam while alert and awake . due to the small size of the tne system , the endoscope can be comfortably passed through the nasal passage instead of through the mouth , avoiding the patient gag reflex – a significant factor in the requirement for sedation in traditional oral exams .
, chairman of vision - sciences , commented ,
during the past several months as we have evaluated the combination of our two companies , we have been thoroughly impressed by uroplasty ' s senior management team and distribution platform . they achieved notable growth with the urgent pc system , and we believe under uroplasty ' s leadership , that our shareholders have the best opportunity to generate value through maximizing the global market potential for the combined company ' s product lines and proprietary technology .
vision - sciences is currently the only provider of an fda - cleared line of transnasal endoscopes for this procedure that utilizes the patented endosheath technology , a cost - effective and safe solution for patients , doctors , hospitals , and other medical facilities . with endosheath technology , the tne endoscope is placed inside a new , sterile cover for each exam . the sheath is discarded after each procedure , guarding against the potential of an unclean endoscope and the risk of bacterial or viral cross - contamination with the next patient .
the transaction is expected to qualify as a tax free reorganization under the internal revenue code . the transaction is subject to customary closing conditions , including approval of the shareholders of each of uroplasty and vision - sciences . in connection with this transaction , the convertible promissory notes held by mr . pell will be amended . the maturity date of the amended notes will be five years from the date of the closing the merger , and interest accrued under the notes shall be calculated quarterly and payable on the maturity date or upon repayment or conversion of all or any portion of the principal . in addition , the notes will not be convertible until the third anniversary of the closing , except in a change in control or if the company decides to prepay the notes . vision - sciences and mr . pell also agreed to extend the period during which he may exercise his warrants , which will be exercisable starting on the third anniversary of the closing and ending on the later of the maturity date of the convertible promissory notes or the date on which the notes are converted or paid in full . the warrants would also be exercisable in the event of a change in control .
, is a global medical device company that develops , manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions . uroplasty ' s focus is the continued commercialization of its urgent® pc neuromodulation system , which uroplasty believes is the only commercially available , fda - cleared device that delivers percutaneous tibial nerve stimulation ( ptns ) for the office - based treatment of overactive bladder ( oab ) . oab is a chronic condition that affects approximately 42 million u . s . adults . the symptoms include urinary urgency , frequency and urge incontinence . uroplasty also offers macroplastique® , an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency . for more information on uroplasty and its products , please visit uroplasty , inc . at
this release includes forward - looking statements intended to qualify for the safe harbor from liability established by the private securities litigation reform act of 1995 . these forward - looking statements generally can be identified by phrases such as vision - sciences or its management
believes ,
expects ,
allows ,
anticipates ,
or other words or phrases of similar import . similarly , statements in this release that describe our business strategy , outlook , objectives , plans , intentions or goals also are forward - looking statements . all such forward - looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward - looking statements . other risk factors are detailed in our most recent annual report and other filings with the sec .
this release includes forward - looking statements intended to qualify for the safe harbor from liability established by the private securities litigation reform act of 1995 . these forward - looking statements generally can be identified by phrases such as vision - sciences or its management
believes ,
expects ,
allows
,
anticipates ,
or other words or phrases of similar import . similarly , statements in this release that describe our business strategy , outlook , objectives , plans , intentions or goals also are forward - looking statements . all such forward - looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward - looking statements . other risk factors are detailed in our most recent annual report and other filings with the sec .
ms . wolf has an extensive background in finance and the health care industry . before joining vision - sciences , ms . wolf was a managing director at hsbc in its investment banking division where she was a founding member of the firm ' s health care group . ms . wolf was responsible for leading the investment banking global medical technology effort , including origination and execution of m & a and corporate finance transactions . while at hsbc , ms . wolf was also a managing director in the firm ' s financial sponsors group . prior to hsbc , she was a managing director in the health care group at bear stearns & co . , and before that , at sg cowen and furman selz . ms . wolf holds an m . b . a . from harvard business school and a b . a . from williams college .
ms . wolf has an extensive background in finance and the health care industry . before joining vision - sciences , ms . wolf was a managing director at hsbc in its investment banking division where she was a founding member of the firm ' s health care group . ms . wolf was responsible for leading the investment banking global medical technology effort , including origination and execution of m & a ; and corporate finance transactions . while at hsbc , ms . wolf was also a managing director in the firm ' s financial sponsors group . prior to hsbc , she was a managing director in the health care group at bear stearns & co . , and before that , at sg cowen and furman selz . ms . wolf holds an m . b . a . from harvard business school and a b . a . from williams college .
except for the historical information provided , the matters discussed in this release include forward - looking statements for the purposes of the safe harbor protections under the private securities litigation reform act of 1995 . these forward - looking statements generally can be identified by phrases such as vision - sciences or its management
believes ,
expects ,
allows ,
anticipates ,
or other words or phrases of similar import . similarly , statements in this release that describe our business strategy , outlook , objectives , plans , intentions , or goals are also forward - looking statements . all such forward - looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those in forward - looking statements . other risk factors are detailed in our most recent annual report and other filings with the securities and exchange commission . we do not assume any obligation to update any forward - looking statements as a result of new information or future events or developments .
this press release includes forward - looking statements . these forward - looking statements generally can be identified by the use of words such as
anticipate ,
expect ,
plan ,
could ,
may ,
will ,
believe ,
estimate ,
forecast ,
goal ,
project ,
and other words of similar meaning . forward - looking statements in this press release include , but are not limited to , statements about the benefits of the transaction ; expected revenue growth rates ; the expected timing of the completion of the transaction ; and the combined company ' s plans , objectives , expectations and intentions with respect to future operations , products and services . each forward - looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement . applicable risks and uncertainties include , among others , uncertainties as to the timing of the transaction ; uncertainties as to whether uroplasty shareholders and vision - sciences shareholders will approve the transaction ; the risk that competing offers will be made ; the possibility that various closing conditions for the transaction may not be satisfied or waived ; the risk that shareholder litigation in connection with the transaction may result in significant costs of defense , indemnification and liability ; other business effects , including the effects of industry , economic or political conditions outside of either company ' s control ; the failure to realize synergies and cost - savings from the transaction or delay in realization thereof ; the businesses of uroplasty and vision - sciences may not be combined successfully , or such combination may take longer , be more difficult , time - consuming or costly to accomplish than expected ; operating costs and business disruption following completion of the transaction , including adverse effects on employee retention and on each company ' s respective business relationships with third parties ; transaction costs ; actual or contingent liabilities ; the adequacy of the combined company ' s capital resources ; and the risks identified under the heading
risk factors
in uroplasty ' s annual report on form 10 - k , for the fiscal year ended
please check your spelling . try our suggested matches or see results in other tabs .
for inquiries related to this message please contact support . for sales inquiries , please visit urltoken
if you believe this to be in error , please confirm below that you are not a robot by clicking
i ' m not a robot
below .
please make sure your browser supports javascript and cookies and that you are not blocking them from loading . for more information you can review the terms of service and cookie policy .
the spo profiles may contain historical records . please visit the latest spos for the most recent information .
unless otherwise indicated in the applicable prospectus supplement , we intend to use the net proceeds from the sale of the securities under this prospectus for general corporate purposes , including payment of expenses , working capital and repayment , in whole or in part , of outstanding indebtedness under our amended and restated loan agreement with lewis c . pell , the chairman of our board of directors ( the “loan agreement” ) dated as of september 30 , 2011 , and to otherwise meet the company’s liquidity needs . at this time , we have not determined the specific uses of any offering proceeds , or the amounts we plan to spend on any particular use or the timing of such expenditures . pending application of the net proceeds from any particular offering , we intend to invest such proceeds in short - term , interest - bearing , investment - grade securities . subject to the terms of the loan agreement , we may borrow an aggregate of up to $ 10 million , of which $ 8 . 0 million ( in accrued interest and principal ) is outstanding as of the date of this prospectus . under the loan agreement , we are required to apply ( i ) 100 % of the net proceeds from the sale of equity to a third - party to the amounts outstanding up to $ 5 million and ( ii ) ( a ) the applicable percentage ( defined below ) times ( b ) the amount of such proceeds in excess of $ 5 million , to repay outstanding amounts under the loan agreement . “applicable percentage” means 20 % upon receipt by the company of $ 5 million of net proceeds beyond the initial $ 5 million in net proceeds . this percentage increases on a straight line basis up to 100 % upon receipt of cumulative net proceeds to the company of at least $ 15 million . each time we issue securities , we will provide a prospectus supplement that will contain information about how we intend to use the proceeds from each such offering . we cannot guarantee that we will receive any proceeds in connection with any offering hereunder because we may choose not to issue any of the securities covered by this prospectus .
medical segment : competition we believe that the primary competitive benefits in the medical market for our flexible endoscopes and endosheath technology are safety and effectiveness , the optical quality of our product offering , product reliability , price , physician familiarity with the manufacturer and its products , ease of use and third - party reimbursement policies . our ability to compete is directly affected by several factors , such as our sales and marketing capabilities , our product development and innovation capabilities , our ability to obtain required regulatory clearances , our ability to protect the proprietary technology which our products are based upon , our manufacturing skills and our ability to attract and retain skilled employees . our current and future product lines face global competition , primarily from companies such as olympus , pentax , and karl storz . some of our competitors and some potential competitors may have greater financial resources , sales and marketing personnel and capabilities , research and development , and manufacturing personnel and capabilities than we do . in addition , any company that is able to significantly redesign conventional flexible endoscopes to simplify the disinfection process , or significantly improve the current methods of disinfecting flexible endoscopes , may result in competition for our products . we believe our proprietary endosheath technology platform currently allows us a significant differentiating factor from our competition . currently , all our competitors are selling endoscopes that require elaborate and time - consuming disinfection procedures . - - - industrial segment : competition in our industrial markets , we believe that our over 35 year history of product effectiveness , ease of use , product reliability and competitive pricing are the principal competitive factors to our success . among our competitors are olympus , ge inspection technologies , and karl storz industrial .
edgar® online , a division of donnelley financial solutions . edgar® is a federally registered trademark of the u . s . securities and exchange commission . edgar online is not affiliated with or approved by the u . s . securities and exchange commission .
enter up to 25 symbols separated by commas or spaces in the text box below . these symbols will be available during your session for use on applicable pages .
please note that once you make your selection , it will apply to all future visits to nasdaq . com . if , at any time , you are interested in reverting to our default settings , please select default setting above . if you have any questions or encounter any issues in changing your default settings , please email isfeedback @ urltoken .
you have selected to change your default setting for the quote search . this will now be your default target page ; unless you change your configuration again , or you delete your cookies . are you sure you want to change your settings ?
please disable your ad blocker ( or update your settings to ensure that javascript and cookies are enabled ) , so that we can continue to provide you with the first - rate market news and data you ' ve come to expect from us .
, where uroplasty ' s current headquarters is located . cogentix medical will be led by
endosheath endoscopy , which combines state - of - the - art endoscopic technology with a sterile , disposable microbial barrier , provides practitioners and healthcare facilities with a solution to meet the growing need for safe , efficient , and cost - effective flexible endoscopy . in addition to the combined company ' s increased presence in urology , the combination of the two companies will provide a platform for growth in other specialties that currently perform endoscopic procedures in hospitals and physician offices , which represents an addressable market opportunity of over
u . s . eastern standard time . this call can be accessed in three ways :
by telephone : for both
listen - only
participants and those who wish to take part in the question - and - answer portion of the call , the telephone dial - in number in the u . s . is ( 888 ) 806 - 6230 . for participants outside the u . s . , the dial - in number is ( 913 ) 312 - 0398 . the access code for all callers is 2077980 .
. the dial - in number for u . s . participants is ( 888 ) 203 - 1112 . for participants outside the u . s . , the replay dial - in number is ( 719 ) 457 - 0820 . the replay access code for all callers is 2077980 .
investors are urged to read the joint proxy statement / prospectus when it becomes available , because it will contain important information .
copyright © 2018 pr newswire association llc . all rights reserved . a cision company .
html public
- / / w3c / / dtd xhtml + rdfa 1 . 0 / / en
urltoken
enter your email address and name below to subscribe to any of our free e - newsletters .
sign up for a free crunchbase account to follow and track organizations you care about .
descriptive keyword for an organization ( e . g . saas , android , cloud computing , medical device )
this field describes an organization ' s most recent funding status ( e . g . early stage venture , late stage venture , m & a )
last funding round type ( e . g . series a , seed , private equity )
transaction name : auto - generated name of transaction ( e . g . angel - uber )
html public
- / / w3c / / dtd xhtml 1 . 0 transitional / / en
urltoken
this no - sedation method is a viable first line approach in diagnosing diseases of the esophagus . the lack of a need for sedation eliminates the risks and complications associated with sedation and physicians should be discussing this alternative to traditional endoscopy with their patients ,
stated howard siegel , m . d . , founding partner at manhattan internal medicine associates , p . c .
howard zauberman , president and chief executive officer , is available for in - person meetings or phone interviews . please contact mitch kayden at ( 845 ) 709 - 5607 or mkayden @ urltoken for more information or to set up an interview .
© 1985 - 2018 biospace . com . all rights reserved . powered by madgex job board software
distribution of company announcements to the professional platforms , finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems .
globenewswire is one of the world ' s largest newswire distribution networks , specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media , investment community , individual investors and the general public .
we use cookies on this site to enable your digital experience . by continuing to use this site , you are agreeing to our cookie policy . close
data on cases , clients , outside counsel and individual attorneys collected from active federal civil cases . reflects only recently published court data ; not intended to be exhaustive . not responsible for errors in court dockets .
to view all the results and drill down deeper , take a free trial now .
gilead ' s portfolio of products and pipeline of investigational drugs includes treatments for hiv / aids , liver diseases , cancer , inflammatory and respiratory diseases , and cardiovascular conditions .
our portfolio of marketed products includes a number of category firsts , including complete treatment regimens for hiv infection available in a once - daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring hiv infection in certain high - risk adults .
collaborations of all kinds – with partners in science , academia , business and local communities – are central to our work . partnerships enhance our ability to develop innovative medicines and deliver them to people as efficiently as possible .
gilead was founded in 1987 in foster city , california . since then , we have grown to become one of the world’s largest biopharmaceutical companies , with more than 10 , 000 employees across six continents .
at gilead we are inspired by the opportunity to address unmet medical needs for patients living with life - threatening diseases around the world .
© 2009 - 2018 gilead . all rights reserved . terms of use | privacy statements | cookie statement
the origins of the institute for psychological research and application ( ipra ) can be traced back to 1981 . in 1981 an institute designed to provide consulting and research services to local and national organizations was created in the bgsu department of psychology . this institute was originally named the institute for organizational research and development ( iord ) . in 1987 , it was decided that the focus of iord was too narrowly defined and did not involve faculty from across the psychology department or the university . therefore , the department proposed to expand the mission of iord in its application for a state of ohio academic challenge award . the industrial / organizational psychology program received this competitive award in 1989 . as a result , the name iord was changed to ipra , and the institute became a broader - based organization open to intra and inter - departmental collaborative efforts so as to address and meet a diverse set of client needs for professional services . the goals of ipra are to :
since our inception , we have worked with a great number of clients . here is a partial list of our clients .
bgsu offers alternative versions of all of its pages for our users . you can select the high - contrast version below to persist throughout your bgsu website experience .
bowling green state university ( bgsu ) has built its website around the standards of the world wide web consortium ' s ( w3c ) hyper text markup language ( html ) 5 and cascading style sheets ( css ) . the website was built in compliance with the accessibility standards established by section 508 of the rehabilitation act and detailed in section 1194 . 22 of the code of federal regulations ,
web - based intranet and internet information and applications
( urltoken ) .
bgsu utilizes many webmasters across campus to maintain all of its web properties . keeping the bgsu website in compliance with section 508 is a joint effort between accessibility services , marketing and communications and information technology services . if any page is discovered to be inaccessible , please report it using the above link and we will ensure that the issue is addressed .
to our guests with disabilities , please indicate if you need special services , assistance or appropriate modifications to fully participate in this event by contacting accessibility services , access @ urltoken , 419 - 372 - 8495 . please notify us prior to the event .
html public
- / / w3c / / dtd html 4 . 01 / / en
urltoken
dr . polsky built an international reputation as an expert in infectious diseases at memorial sloan - kettering cancer center , where he also held the academic title of associate professor of medicine at cornell university medical college . dr . polsky is currently chairman of the department of medicine , chief of the division of infectious diseases , hospital epidemiologist and medical director of the clinical virology laboratory at st . luke ' s - roosevelt hospital center in new york city . dr . polsky also serves as the john h . keating sr . professor of clinical medicine at the college of physicians and surgeons of columbia university .
dr . polsky is a graduate of the university of michigan and the wayne state university school of medicine . his post - graduate training in internal medicine was at montefiore medical center and the albert einstein college of medicine in new york city , followed by a fellowship in infectious diseases at memorial sloan - kettering cancer center and cornell university medical college , where he joined the faculty upon completion of his training in 1986 , remaining until 1998 .
dr . polsky has been active in clinical investigations in hiv and infections complicating neoplastic disease and aids since the early 1980s . more recently , he has focused on the growing problem of hepatitis c and hepatitis b co - infection with hiv . a member of numerous medical societies in his field of specialty , dr . polsky has published over 200 peer - reviewed book chapters , research studies , clinical abstracts and professional journal articles .
microsoft named satya nadella on tuesday as its new chief executive officer . nadella , who joined the software company 22 years ago , replaces steve ballmer .
british pm : u . s . doesn’t want us to leave eu , putin does


kaikai kiki co. is an art production and artist management company founded by the artist takashi murakami of japan .

the company 's primary goals include the production and promotion of artwork , the management and support of select young artists , general management of events and projects , and the production and promotion of related merchandise .

the company and its galleries represent a number of prominent international artists including takashi murakami , kaws , mark grotjahn , matthew monahan , anselm reyle , aya takano , chiho aoshima , ob , mr. , chinatsu ban , rei sato and friedrich kunath .

the company has offices in tokyo and new york as well as affiliates in berlin and taiwan .

kaikai kiki

© takashi murakami / kaikai kiki co . , ltd . all rights reserved .
copyright ( c ) 2005 kaikai kiki co . , ltd . all rights reserved .
takashi murakami eye badge pin superflat pop art kaikai kiki co . authentic item from japan .
takashi murakami eye badge pin superflat pop art kaikai kiki ltd . authentic item from japan .
glassdoor gives you an inside look at what it ' s like to work at kaikai kiki new york , including salaries , reviews , office photos , and more . this is the kaikai kiki new york company profile . all content is posted anonymously by employees working at kaikai kiki new york .
i applied online . i interviewed at kaikai kiki new york ( long island city , ny ) .
takashi murakami flower badge pin superflat pop art kaikai kiki co . authentic item from japan . limited edition .
from june 28 to july 18 , 2018 , kaikai kiki gallery is proud to present rainbow bridge , a solo exhibition of works by american artist wendy white .
kaikai kiki motoazabu crest bldg . 2f 2 - 3 - 30 motoazabu , minato - ku tokyo 106 - 0046 tel : 03 - 6823 - 6039 fax : 03 - 3442 - 5997 kaikai kiki miyoshi factory higashi 2 - 6 , chikumazawa , miyoshi - cho , iruma - gun , saitama 354 - 0046 tel : 049 - 274 - 3260 fax : 049 - 259 - 6470 kaikai kiki miyoshi delivery center higashi 2 - 5 , chikumazawa , miyoshi - cho , iruma - gun , saitama 354 - 0046 tel : 049 - 274 - 3296 fax : 049 - 257 - 1324 kaikai kiki new york 5 - 17 46th road long island city , ny 11101 tel : 718 - 706 - 2213 fax : 718 - 706 - 2218
in 2000 , murakami created two new characters , kaikai and kiki , who featured prominently in murakami’s new work . their names recall the term ' kaikaikiki ' used in the late sixteenth century to describe the work of the painter eitoku kanô as being both ‘powerful and sensitive’ .
rainbow bridge comprises a selection of works from white’s fotobild , multiple - canvas , portraits , and jeans series ( 2012 to 2018 ) curated by takashi murakami , as well as four new works that will be exhibited for the first time in tokyo . we invite you to experience the vibrant worldview of wendy white through her first solo show at kaikai kiki gallery .
html public
- / / w3c / / dtd xhtml 1 . 0 transitional / / en
urltoken
html public
- / / w3c / / dtd xhtml 1 . 0 strict / / en
urltoken
197 madison . 2012 . acrylic on two canvases , inkjet print on vinyl . 2438 x 3048 x 76 mm .
in norse mythology , the rainbow bridge is a passage between earth and the realm of the gods . for this exhibition , the bridge is a metaphor for athletic expression and artistic creation . like artists , athletes train in solitude for countless hours in order to perform what is often a split - second act of improvisation— moments either seized or wasted . those moments are as much fleeting glimpses as they are concrete ideas . athletes often talk of a near unconscious state , or “the zone , ” in which they are able to perform almost without thinking . in an artist’s studio , this state is like the moment of liftoff for a ski jumper ; both tangible and intangible ; at once an impossible feat and an absolute necessity .
the artist attempts to capture this effect in works like elan ( sara takanashi ) , 2015 , which depicts the champion skier in mid - flight—a moment of pure expression . conversely , in fischer ( ernest yahin ) , the athlete is mid - wipeout , thus memorializing a spectacular moment of failure , which is also an essential part of training and learning .
in a series of three multiple - canvas portraits of racecar drivers from the 1970s and 80s , the athletes are set off by neon , rainbow - like bands , a testament to their tenacity and the rarity of women in a macho , male - dominated arena . glossy black corner rainbows span the space between canvases , creating a visual and physical connection between moments captured by photography .
197 madison , 2012 , is based in part on the writings of michel de certeau , in which he describes walking in the city as an invisible , poetic layer of footpaths . the work combines a photograph of a new york city bodega sign with graffiti - inspired marks and quasi - legible text , celebrating the city’s visual layers , both organic and imposed .
jeans , 2017 , a free - form wall installation made from deconstructed men’s denim jeans , is a meditation on american symbolism— something rough and durable transformed into a celestial starscape . in other jeans works on canvas , the material is a stand - in for both landscape and directional brushstroke . pollock - like splatters are a nod to canonized gestures as well as natural wear and tear , and the inclusion of colorful bands , or skies , offers an atmospheric juxtaposition to what is a particularly american version of nostalgia .
i’m not an artist who makes the same painting over and over . i can’t . instead i try to push forward , ruthlessly , testing the boundaries of the medium .
i am honored that takashi murakami not only understood that impulse , but championed it by selecting a diverse yet coherent body of work from my archive to present . sometimes it takes someone else’s eye to see new connections , and i’m very grateful to have that in this instance .
rainbow bridge began as a smaller show . when we expanded the scope to include older works , the concept expanded with it , coming to represent not only a bridge between works but also a journey in itself . i tend to respond to personal and cultural impulses in my work in real time . my interest in athletics as pure human expression , symbols of optimism as metaphors for emotional states , and the rainbow itself as a mutable , intangible entity are amplified by this uncertain time in american history . i find myself looking backwards and forwards at the same time , hoping we stick the landing .
this , the first presentation of takashi murakami’s work in the uk , included his paintings , sculptures and wallpaper made from 1999 to the time of the exhibition .
these recent works included murakami’s 1993 invention , mr dob , a comic - like character that became his signature , logo and alter ego and makes a regular appearance in his paintings , sculptures , t - shirts and other merchandise . murakami’s recent paintings showed mr dob morphed into a half - cartoon , half - monster figure .
notice :
this website is not optimised for your browser , and some items may not display or perform properly . please upgrade your browser for a full experience .
as a logged - in user you will be able to save your favorite artworks , galleries , artists and events . you can also access exclusive features and subscribe to our newsletters .
as a registered user you will be able to save your favorite artworks , galleries , artists and events . you can also access exclusive features and subscribe to our newsletters .
thank you for registering with art basel . a confirmation email has been sent to you . please click on the link in the email in order to complete your registration .
the confirmation email can take a few minutes to arrive . please be sure to check your spam or junk folders if you did not get the confirmation email within a reasonable amount of time . if you encounter any problems , please contact support @ urltoken .
please enter your email address below and a new temporary password will be sent to you . follow the instructions in the email to reset your password .
sorry - there appears to be a problem connecting to our server . please refresh the page and try again . if the problem persists , please try again later . we apologize for any inconvenience .
2018 hypebeast limited . all rights reserved . hypebeast® is a registered trademark of 101 media lab , ltd .
2018 hypebeast limited . all rights reserved . hypebeast® is a registered trademark of 101 media lab , ltd .
share your ideas , get instant updates and enjoy exclusive deals at our store .
by signing up , you agree to our terms of use and privacy policy .
receive the latest in footwear , fashion , music and creativity in our newsletters .
118 1 / 8 x 239 3 / 8 x 2 in . ( 300 . 04 x 608 . 01 x 5 . 08 cm )
glassdoor will not work properly unless browser cookie support is enabled . learn how to enable cookies .
explore the many benefits of having a premium branded profile on glassdoor , like increased influence and advanced analytics .
great chance to know the process of how the world - famous artists make their works .
applied through an online job board . first interview in the office with mostly basic questions about experience and interest in the fine art . they had someone check my japanese and english language skill . second / final interview was done at a nearby bar because they want to see if you can hold your alcohol and how you interact with bar staff . . . however you will not be told about this beforehand . after this they went silent for weeks before finally providing a job offer for a totally different job .
copyright © 2008–2018 , glassdoor , inc .
glassdoor
and logo are proprietary trademarks of glassdoor , inc .
new in bag , tshirt by artisttakashi murakami made exclusively for complexcon in long beach california . this one is super rare with sewn neck label . size large .
new in bag , teeth tshirt by artisttakashi murakami made exclusively for complexcon in long beach california . this one is super rare with sewn neck label . size : large .
copyright © 1995 - 2018 ebay inc . all rights reserved . accessibility , user agreement , privacy , cookies and adchoice
this page was last updated : jul - 09 13 : 05 . number of bids and bid amounts may be slightly out of date . see each listing for international shipping options and costs .


novus leisure ( also a3d2 ltd ) is a british company which operates 47 bars and nightclubs in the united kingdom .

tim cullum and gregor grant are in charge of the company .

the company is owned by lgv capital and hutton collins , who purchased novus for £ 100m in 2012 .

their operations include the tiger tiger chain of nightclubs , and a number of venues in the city and west end areas of london .

novus leisure

glassdoor has 27 novus leisure reviews submitted anonymously by novus leisure employees . read employee reviews and ratings on glassdoor to decide if novus leisure is right for you .
copyright © novus leisure limited 2017 | registered in england and wales no . 06934120
ask a question about working or interviewing at novus leisure . our community is ready to answer .
venues which are part of novus leisure ' s late night london portfolio . | venues & events - square meal
novus leisure , the 52 - strong bar and nightclub operator , has been bought by lgv capital and hutton collins for £100m .
50 % food & drink discount in all novus leisure venues . tank & paddle heddon street – bars managers . . . .
novus property solutions * . the successful candidate will have strong experience in construction / minor build and refurbishment within the leisure , retail , . . .
“these attributes have resulted in keen interest by the private equity community to invest in the next stage of novus’ development and in lgv and hutton collins we have secured investors who have an enviable record of backing successful businesses in the leisure sector . we really look forward to working with them over the next few years and to maximise the growth potential of novus leisure . ”
hospitality / leisure sector experience ( service / sales / marketing ) . head of marketing . . . .
rothschild advised novus , barclays ventures and rbs strategic investment group . deloitte advised lgv . zolfo cooper advised hutton collins .
“looking further forward novus also has the potential to expand outside its london core to cities such as manchester , bristol and leeds . ”
“when investing we look for a differentiated product , strong growth prospects and a high performing management team , novus ticks all those boxes and we’re looking forward to helping the company to grow . ”
richards said : “novus has a resilient model that has served it well over the years . our focus and investment in our pre - booked system has given us the ability to take market share and deliver predictable high quality earnings .
working under novus can be stressful sometimes , it gives the best of example of ' it ' s a small word ' as everyone knows literally everyone . none the less , it ' s an exciting company to work for .
bill priestley , a managing director at lgv capital , said : “we are delighted to have completed this acquisition . novus has one of the best collection of bars and venues in the uk , which , together with its website , urltoken has enabled it to outperform its market and peer group for some years .
the move is set to see novus continue its expansion in london and further afield , with the group given access to tens of millions of pounds of growth funding to strengthen its existing footprint and double profitability . the deal will also consolidate and strengthen the group ' s market leading position in the premium bar london market .
lgv and hutton collins said they have backed the existing management team led by chief executive steve richards , effectively ending speculation linking him with the vacant ceo position at mitchells & butlers . john kelly will remain as non - executive chairman .
lgv capital and hutton collins will take joint ownership of the highly - regarded operator . the statement said that the deal has “provided a value exit” for the incumbent majority shareholders barclays ventures and rbs strategic investment group .
the statement said : “lgv and hutton collins will support the group’s future strategy to double its central london portfolio over the next three years .
“we are backing a first class management team , led by steve richards , and look forward to developing the business by growing the estate through acquisitions . ”
“this will be lgv’s fifth investment in the pubs and bars sector . we backed the original start up of enterprise inns before it floated in 1995 , co - funded the acquisition of the unique pubco , which was sold to enterprise inns in 2004 , backed the 2008 management buy - out of the liberation group , the channel islands’ leading pub company and brewer and acquired amber taverns , the northern community pub specialist in 2010 . ”
graham hutton of hutton collins said : “although hutton collins has not invested in this specific sector before , we have a depth of knowledge in the closely related dining sector , having previously made successful investments in pizza express and loch fyne , and having significant continuing investments in caffè nero and wagamama .
confirmation statement made on 03 / 02 / 18 , with updates - £4 . 99
privacy policy - terms - contact - copyright © companies in the uk ltd 2018 all rights reserved .
abbey is an eclectic , eccentric escape from the daily grind . with a restaurant , bar and club abbey is the perfect place to relax and recharge by day , then party through the night . at abbey we ' re all about the good times . join us for after drinks , dance into the early hours and refuel with our delicious and ever - evolving menu . enjoy our happy hour every day - the perfect after work treat . challenge your friends to a game of ping pong , shake it on the dance floor or relax back in our reserved booths . enjoy the lighter side of life .
forge bar is in the heart of london ' s city , near ba . . .
fantastic opportunity at balls brothers victoria ! bar staff and wait staff wanted £7 . 50ph + service charge balls brothers victoria is a contemporary venue moments from buckingham palace , victoria station and some of london’s most popular stage productions . . . .
area chef de partie – balls brothers ltd full time position ( approx . 40 hours per week ) up to £10 ph + service charge / tronc balls brothers is a strong and successful brand , with an excellent reputation within the industry , holding 10 venues across london . this is an . . .
sales manager – tiger tiger manchester we are a looking for a talented sales manager with a proven track record to lead and develop the team and business here at tiger tiger , manchester . tiger tiger has stood out as one of manchester’s biggest bar , nightclub and event spaces for over . . .
there are currently no vacancies listed , please check again soon for any new vacancies that arise .
glassdoor will not work properly unless browser cookie support is enabled . learn how to enable cookies .
your trust is our top concern , so companies can ' t alter or remove reviews .
absolutely nothing , the worst company your could ever work for . your simple health and safety rights are breached , let alone your are never paid for the hours you actually do . hours are cut from your pay without reason and when you bring it to attention you are told you ' ll be paid for next pay but the same thing happen over and over .
staff are seen as animals and are used and abused by management . no prospect to progress as you need to know management or offer yourself to them sexually in order to be promoted . good simple hard work definitely does not pay of !
change your organisational traits , otherwise one day soon it ' ll catch up with you in the news and papers .
low payments on all level bully managers people there , turn blind eyes over unacceptable treatment towards staff more than breathing air . incompatible people with atrocious behavior in general manager position profit over people always
senior management fill your head with lies and dreams , ask & expect you to jump through hoops with promises of pay rises and promotions then do not deliver when promised . awful hr - refuse to deal with hr complaint and encourage you to be quiet and just transfer sites . one of the area sales managers has had more than 8 hr complaints and it has just be brushed under the carpet . started full of life , committed , happy to put in all the extra hours and now i am just disheartened and drained .
stop selling dreams , pushing people out to cover yourselves , oh and walking into venues spreading your employees private business . this is a business not a school !
this will replace the current featured review for targeted profile . are you sure you want to replace it ?
copyright © 2008–2018 , glassdoor , inc .
glassdoor
and logo are proprietary trademarks of glassdoor , inc .
this website uses ' cookies ' to give you the best , most relevant experience . using this website means you ' re happy with this . you can find out more about the cookies used by
sorry , but your web browser is too old to display this page properly . please update it to the latest version or switch to a more modern browser , like firefox , opera , google chrome or safari or internet explorer 11 ( they ' re all free ) .
for inquiries related to this message please contact support . for sales inquiries , please visit urltoken
if you believe this to be in error , please confirm below that you are not a robot by clicking
i ' m not a robot
below .
please make sure your browser supports javascript and cookies and that you are not blocking them from loading . for more information you can review the terms of service and cookie policy .
tip : enter your city or postcode in the
where
box to show results in your area .
these include a share save scheme , life assurance , holiday buy and many more designed to suit your own personal lifestyle , such as retail , health & wellbeing . . .
experienced floor service staff required for very busy covent garden cocktail bar and club . applicants must be confident , highly presentable and excellent . . .
we are looking for a full time senior chef who is able to work solely and on busy shifts with junior trainee in late night venue , current menu consists of . . .
ruby blue in leicester is looking for cocktail bar staff & vip waitress / waiter , host & hostess and restaurant supervisor . job types : full - time , part - time . . .
by creating a job alert or receiving recommended jobs , you agree to our terms . you can change your consent settings at any time by unsubscribing or as detailed in our terms .
cookies help us deliver our services . our cookie policy describes how we use cookies and how to disable them . learn more · ok
alot is expected from you . difficult company to work for as there is constant pressure . not alot of job security but knowledge gained and good experience
me han tratado estupendamente todos los años que estuve con ellos . me dieron la oportunidad de ascender desde limpia platos a ayudante de cocina y me enseñaron una profesion . luego me dieron la oportunidad de seguir ascendiendo y moviéndose por distintos restaurantes de la compañía , por el único echo de seguir aprendiendo
lovely company to work for - you can learn a lot ! you will meet lot of people and make new friends - very easy to move on to a different company as you get experience in lot of different sectors .
the job role in it self was a great one . i not only got to work there was a lot of play involved . i was one of the lucky ones to stay in the role for as long as i did . a lot of people did not last in the role for longer than a few weeks . its very demanding and needs someone who can handle that type of pressure .
productive and fun workplace , each day is different . more emphasis could be put into training . working environment could be worked on . diverse individuals and diverse events to indulge in .
my work day varied as the beginning of the week i would deal with more sales part of the business , where i would have to review my weekly shows , i would usually work a month in advance . i would look to see if there was any way to up sell my clients to a 3 course meal and maybe a private area in the club after their show and meal . draw up seating plan for the upcoming show and liase with chef regarding any food pre orders . generally making sure everything was prepared for the weekend coming . on the weekends i would be overseeing at least 20 staff to ensure the bar was stocked and all bar tenders and waiters / waitress were positive and productive to drive sales and ensure repeat busines . make sure all my comedians were on time and my show would run smoothly and efficiently . deal with any mix ups or customer complaints on the night . this is something i was very good at as customer satisfaction was so important to me and also ensuring we delivered what the sales team had promised . cashing up at the end of each shift and closing down tills . drawing up the profits in table to forward to the gm . i would basically be the 1st point of contact and the last . i enjoyed my job , it was very hands on and every day was different . we really like on little family and all had the same motive which was to make money .
the shifts are mainly organised during the weekends , and they are looong . christmas period is the crazy one , where you possibly will work 6 or 7 days a week . it ' s good to work in such a job if you ' re a student , but i don ' t think you can make a living from it of what they ' re paying to bar support and bartenders . some of the management is ok , but gm ' s are mostly very rude and has no interest in their staff ( just my own experience ) . hardest thing when you ' re working as a bartender is the cleaning process after a 12 / 14 hours shift on a sunday morning . sometimes you can ' t even stand on your feet anymore and you still have to do this . if there is a great team working with you by the bar , you make really good memories , because the surrounding itself is fun and entertaining .
• maximise advanced sales , encompassing all aspects of corporate and pre - booked sales ( i . e . corporate events , guest lists , booth bookings and all reservations ) . reactive and proactive selling . • work to pre - determined targets for advanced sales as set by the venue sales manager , maximising all opportunities to achieve these • manage the sales executive , ensuring their weekly working diary is arranged each week for the following . • continually build and validate a database of contacts with key employers , organisations and private customers . ( crm trained ) . • ensure smooth delivery of key events from concept to execution . • plan effectively for successful delivery of the crucial christmas and new year’s eve business targets • be creative , resourceful and provide feedback to other areas of the business such as commercial and operational .
my day mainly consisted of a lot of calls and meetings with clients to discuss their event requirements . i have learned never to assume anything . i always got on with everyone that i have worked with , management and co - workers . the hardest part of the job were the cold calls which i am not looking to make again . the most enjoyable part of the job was meeting and organising my client ' s events .
long and late hours in a very busy bar good team ethic management sometimes a little wayward .
i am in charge of all the advanced sales and events management in my venue . i manage a team of 3 , everyone has their tasks and works to increase the venue performance in advanced sales and develop existing and new business relationships . i have a great relationship with all of my colleagues and superiors . great team spirit . proactive sales are very challenging but nothing that you can ' t do with a great team . the part of the job that i like the most is dealing with corporate clients and organizing big events .
while here i gained extensive knowledge of peaks and troughs , current and past trends within the hospitality and events sector . a typical day at work would be contacting previous customers or clients to encourage them to return and inform them of any upcoming events . the hardest part of the job would be the long hours but even they weren ' t unmanageable . the most enjoyable part of the job would be my colleagues .